Fig. 2From: The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phaseTumor suppressors network associated with the BCR-ABL/MAPK pathway. Representation of the tumor suppressors involved in the RAS/MEK/ERK pathway and the JAK2/β-catenin pathway. DOK family proteins are involved in the negative regulation of RAS activation. Representation of the IRF pathway. Finally, morgana/chp-1 pathway is indicatedBack to article page